Canadian CANNAINVESTOR Magazine November 2017 - Page 64

Q&A

CCIM: Before we wrap up, is there anything not discussed that you would like for our readers to been aware of?

BE: Beleave is a research forward company with a talented pool of scientists that have over the years brought many innovations to the fields of plant biology and analytical chemistry. We are working daily with individuals that have a genuine desire to further medical cannabis research. Almost all of this research is being funded through government grants, academic institutions and personal commitments. It is our belief that this self-driven enthusiasm is eventually going to be what drives shareholder value.

CCIM: Thank you so much for your time. Is there an email or link our readers can learn more? Will an updated corporate presentation (investors’ deck) be available?

BE: Visit www.beleave.com and take a look at the Invest page.

Q: CannaInvestor Magazine (CCIM)

Louis Kyron, CPA, CGA

A: Roger Ferreira PhD., former CEO

Beleave, Inc. (BE)

64

CSE:BE;

OTCQX:BLEVF